Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons™

Open Access. Powered by Scholars. Published by Universities.®

Cancer

Discipline
Institution
Publication Year
Publication
Publication Type
File Type

Articles 1201 - 1230 of 2186

Full-Text Articles in Medicine and Health Sciences

Comparative Survival Of Asian And White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel, Susan Halabi, Sandipan Dutta, Catherine M. Tangen, Mark Rosenthal, Daniel P. Petrylak, Ian M. Thompson Jr., Kim N. Chi, Johann S. De Bono, John C. Araujo, Christopher Logothetis, Mario A. Eisenberger, David I. Quinn, Karim Fizazi, Michael J. Morris, Celestia S. Higano, Ian F. Tannock, Eric J. Small, William Kevin Kelly Jan 2020

Comparative Survival Of Asian And White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel, Susan Halabi, Sandipan Dutta, Catherine M. Tangen, Mark Rosenthal, Daniel P. Petrylak, Ian M. Thompson Jr., Kim N. Chi, Johann S. De Bono, John C. Araujo, Christopher Logothetis, Mario A. Eisenberger, David I. Quinn, Karim Fizazi, Michael J. Morris, Celestia S. Higano, Ian F. Tannock, Eric J. Small, William Kevin Kelly

Mathematics & Statistics Faculty Publications

There are few data regarding disparities in overall survival (OS) between Asian and white men with metastatic castration-resistant prostate cancer (mCRPC). We compared OS of Asian and white mCRPC men treated in phase III clinical trials with docetaxel and prednisone (DP) or a DP-containing regimen. Individual participant data from 8820 men with mCRPC randomly assigned on nine phase III trials to receive DP or a DP-containing regimen were combined. Men enrolled in these trials had a diagnosis of prostate adenocarcinoma. The median overall survival was 18.8 months (95% confidence interval [CI] = 17.4 to 22.1 months) and 21.2 months (95% …


Evaluation Of Mitochondrial Dna Copy Number Estimation Techniques, Ryan J Longchamps, Christina A Castellani, Stephanie Y Yang, Charles E Newcomb, Jason A Sumpter, John Lane, Megan L Grove, Eliseo Guallar, Nathan Pankratz, Kent D Taylor, Jerome I Rotter, Eric Boerwinkle, Dan E Arking Jan 2020

Evaluation Of Mitochondrial Dna Copy Number Estimation Techniques, Ryan J Longchamps, Christina A Castellani, Stephanie Y Yang, Charles E Newcomb, Jason A Sumpter, John Lane, Megan L Grove, Eliseo Guallar, Nathan Pankratz, Kent D Taylor, Jerome I Rotter, Eric Boerwinkle, Dan E Arking

Faculty, Staff and Student Publications

Mitochondrial DNA copy number (mtDNA-CN), a measure of the number of mitochondrial genomes per cell, is a minimally invasive proxy measure for mitochondrial function and has been associated with several aging-related diseases. Although quantitative real-time PCR (qPCR) is the current gold standard method for measuring mtDNA-CN, mtDNA-CN can also be measured from genotyping microarray probe intensities and DNA sequencing read counts. to conduct a comprehensive examination on the performance of these methods, we use known mtDNA-CN correlates (age, sex, white blood cell count, Duffy locus genotype, incident cardiovascular disease) to evaluate mtDNA-CN calculated from qPCR, two microarray platforms, as well …


Impact Of Chlorpyrifos Exposure On Colorectal Cancer In Agricultural Communities In Ohio, Vicky Knisley-Henry Jan 2020

Impact Of Chlorpyrifos Exposure On Colorectal Cancer In Agricultural Communities In Ohio, Vicky Knisley-Henry

Walden Dissertations and Doctoral Studies

Colorectal cancer (CRC) is the third leading cancer diagnosis in the United States, and second in Ohio, for both men and women. In 2019, there were an estimated 145,000 cases of new CRC diagnoses and will lead to more than 50,000 deaths. Results from a systematic review indicate that chlorpyrifos use in agriculture is linked to the incidence of breast and lung cancers and has a possible association with CRC. Grounded in the social-ecological model, this study investigated the association between exposure to chlorpyrifos and CRC rates in agricultural communities in Ohio. The quantitative cohort design method utilized secondary data …


Rna Polymerase I Elongation Kinetics: A Biochemical And Global Study Of A Cancer Therapeutic Target, Catherine Elizabeth Scull Jan 2020

Rna Polymerase I Elongation Kinetics: A Biochemical And Global Study Of A Cancer Therapeutic Target, Catherine Elizabeth Scull

All ETDs from UAB

My graduate research has focused on understanding the elongation kinetics of RNA polymerase I (Pol I), the enzyme responsible for synthesizing ribosomal RNA (rRNA), and defining how inhibition of ribosome biogenesis may be used as a cancer therapeutic strategy. Here, I have defined key biophysical features of Pol I and I have expanded the field’s understanding of Pol I elongation by: 1) characterizing the enzymatic properties of Pol I by mutational analysis of the polymerase itself, and by 2) elucidating the role of DNA sequence on Pol I arrest and nucleolytic cleavage activity. In recent years, Pol I has become …


Education And Assessment Of Psycho-Existential Symptoms To Prevent Suicidality In Cancer Care, David W. Kissane Jan 2020

Education And Assessment Of Psycho-Existential Symptoms To Prevent Suicidality In Cancer Care, David W. Kissane

Medical Papers and Journal Articles

Clinicians acknowledge awkwardness and lack of skills in assessing suicidal symptoms. This requires increased education, screening for psycho-existential symptoms, and the therapeutic targeting of key symptoms. Assessment of hopelessness, pointlessness, low morale, entrapment, anhedonia, loss of control, loss of roles, and the wish to die prove extremely helpful in recognising a suicidal patient. Use of a screening tool for psycho-existential symptoms aids this recognition and empowers referral for treatment. Communication skills training increases each clinician’s skill and provides a strategic sequence to explore symptoms that mediate suicidal thinking. Network analysis research to identify core symptoms suggests that hopelessness, pointlessness, and …


Contralateral Prophylactic Mastectomy For Unilateral Breast Cancer In Women At Average Risk: Systematic Review Of Patient Reported Outcomes, Amilee Srethbhakdi, Meagan E. Brennan, Geaty Hamid, Kathy Flitcroft Jan 2020

Contralateral Prophylactic Mastectomy For Unilateral Breast Cancer In Women At Average Risk: Systematic Review Of Patient Reported Outcomes, Amilee Srethbhakdi, Meagan E. Brennan, Geaty Hamid, Kathy Flitcroft

Medical Papers and Journal Articles

Objective: The rate of contralateral prophylactic mastectomy (CPM) in women with early, unilateral cancer is relatively high and is increasing around the world a previous study. Women choose this option for many reasons other than reducing their risk of future cancer, including symmetry, reasons related to breast reconstruction and attempting to manage fear of recurrence. This systematic review evaluated patient‐reported quality of life outcomes following CPM.

Methods: A literature search of MEDLINE, PubMed and PsycINFO was performed to February 2019. Abstracts and full‐text articles were assessed for eligibility according to pre‐determined criteria. Data were extracted into evidence tables for analysis. …


The Effects Of Autophagy And Senescence On Sensitivity To Cisplatin In Head And Neck Cancer, Zara H. Siddiqui Jan 2020

The Effects Of Autophagy And Senescence On Sensitivity To Cisplatin In Head And Neck Cancer, Zara H. Siddiqui

Theses and Dissertations

While current treatments in cancer, such as chemotherapy and radiation, can generally be effective in eliminating disease in patients, there also exists the possibility of recurrence of cancer cells over time. In patients diagnosed with locally advanced head and neck carcinoma, about 50-60% develop a loco-regional recurrence within two years, and 20-30% of patients develop metastatic disease at distant sites in the body [5]. On a cellular level, one mechanism for this survival may be that natural mechanisms such as autophagy and senescence play a role in allowing cells to survive after undergoing treatment. One standard of care chemotherapy for …


A Geospatiotemporal And Causal Inference Epidemiological Exploration Of Substance And Cannabinoid Exposure As Drivers Of Rising Us Pediatric Cancer Rates, Albert Stuart Reece Jan 2020

A Geospatiotemporal And Causal Inference Epidemiological Exploration Of Substance And Cannabinoid Exposure As Drivers Of Rising Us Pediatric Cancer Rates, Albert Stuart Reece

Research Datasets

Background: Age-adjusted US total pediatric cancer incidence rates (TPCIR) rose 49% 1975-2015 for unknown reasons. Prenatal cannabis exposure has been linked with several pediatric cancers which together comprise the majority of pediatric cancer types. We investigated whether cannabis use was related spatiotemporally and causally to TPCIR.

Methods: State-based age-adjusted TPCIR data was taken from the CDC Surveillance, Epidemiology and End Results cancer database 2003-2017. Drug exposure was taken from the nationally-representative National Survey of Drug Use and Health, response rate 74.1%. Drugs included were: tobacco, alcohol, cannabis, opioid analgesics and cocaine. This was supplemented by cannabinoid concentration data from the …


Nutrition, Body Composition And Physical Activity In Malignant Pleural Disease: Associations With Patient Outcomes And Response To An Exercise Intervention, Emily Jeffery Jan 2020

Nutrition, Body Composition And Physical Activity In Malignant Pleural Disease: Associations With Patient Outcomes And Response To An Exercise Intervention, Emily Jeffery

Theses: Doctorates and Masters

Background: Patients with malignant pleural disease (MPD) have advanced cancer and high symptom burden. Goals of patient care are to optimise health-related quality-of-life (HR-QoL) and participation in daily physical activities. Supportive care interventions such as nutrition and exercise could offer benefit to patients. However, there is a lack of information on the prevalence of low muscle mass (i.e., pre-sarcopenia), malnutrition, inactivity and poor physical functioning in patients with MPD. Additionally, little is known about the factors associated with development of pre-sarcopenia and malnutrition or their associations with patient outcomes.

Purpose: The objectives were to: 1) characterise physical activity levels and …


Clinical Oncology Society Of Australia: Position Statement On Cancer-Related Malnutrition And Sarcopenia, Nicole Kiss, Jenelle Loeliger, Merran Findlay, Elizabeth Isenring, Brenton J. Baguley, Anna Boltong, Alexis Butler, Irene Deftereos, Michelle Eisenhuth, Steve F. Fraser, Rebecca Fichera, Hayley Griffin, Sandi Hayes, Emily Jeffery, Catherine Johnson, Chris Lomma, Barbara Van Der Meij, Carolyn Mcintyre, Tracey Nicholls, Lina Pugliano, Tina Skinner, Jane Stewart, Judy Bauer Jan 2020

Clinical Oncology Society Of Australia: Position Statement On Cancer-Related Malnutrition And Sarcopenia, Nicole Kiss, Jenelle Loeliger, Merran Findlay, Elizabeth Isenring, Brenton J. Baguley, Anna Boltong, Alexis Butler, Irene Deftereos, Michelle Eisenhuth, Steve F. Fraser, Rebecca Fichera, Hayley Griffin, Sandi Hayes, Emily Jeffery, Catherine Johnson, Chris Lomma, Barbara Van Der Meij, Carolyn Mcintyre, Tracey Nicholls, Lina Pugliano, Tina Skinner, Jane Stewart, Judy Bauer

Research outputs 2014 to 2021

© 2020 The Authors. Nutrition & Dietetics published by John Wiley & Sons Australia, Ltd on behalf of Dietitians Australia. This position statement describes the recommendations of the Clinical Oncology Society of Australia (COSA) regarding management of cancer-related malnutrition and sarcopenia. A multidisciplinary working group completed a review of the literature, focused on evidence-based guidelines, systematic reviews and meta-analyses, to develop recommendations for the position statement. National consultation of the position statement content was undertaken through COSA members. All people with cancer should be screened for malnutrition and sarcopenia in all health settings at diagnosis and as the clinical situation …


We Have The Program, What Now? Development Of An Implementation Plan To Bridge The Research-Practice Gap Prevalent In Exercise Oncology, Mary A. Kennedy, Sara Bayes, Robert U. Newton, Yvonne Zissiadis, Nigel A. Spry, Dennis R. Taaffe, Nicolas H. Hart, Michael Davis, Aileen Eiszele, Daniel A. Galvão Jan 2020

We Have The Program, What Now? Development Of An Implementation Plan To Bridge The Research-Practice Gap Prevalent In Exercise Oncology, Mary A. Kennedy, Sara Bayes, Robert U. Newton, Yvonne Zissiadis, Nigel A. Spry, Dennis R. Taaffe, Nicolas H. Hart, Michael Davis, Aileen Eiszele, Daniel A. Galvão

Research outputs 2014 to 2021

© 2020 The Author(s). Background: Exercise has emerged as a promising therapy for people with cancer. Novel programs have been developed to translate research into practice; however, implementation barriers have limited their success in part because successful translation of exercise oncology research into practice requires context-specific implementation plans. The aim of this study was to employ the implementation mapping protocol to develop an implementation plan to support programming of a co-located exercise clinic and cancer treatment center. Methods: The Implementation Mapping protocol, which consists of five specific iterative tasks, was used. A stakeholder advisory group advised throughout the process. Results: …


The Global, Regional, And National Burden Of Oesophageal Cancer And Its Attributable Risk Factors In 195 Countries And Territories, 1990-2017: A Systematic Analysis For The Global Burden Of Disease Study 2017, Farin Kamangar, Dariush Nasrollahzadeh, Saeid Safiri, Sadaf G. Sepanlou, Christina Fitzmaurice, Kevin S. Ikuta, Catherine Bisignano, Farhad Islami, Gholamreza Roshandel, Stephen S. Lim, Hassan Abolhassani, Eman Abu-Gharbieh, Rufus Adesoji Adedoyin, Shailesh M. Advani, Muktar Beshir Ahmed, Miloud Taki Eddine Aichour, Tomi Akinyemiju, Chisom Joyqueenet Akunna, Fares Alahdab, Vahid Alipour, Amir Almasi-Hashiani, Abdulaziz M. Almulhim, Nahla Hamed Anber, Alireza Ansari-Moghaddam, Jalal Arabloo, Morteza Arab-Zozani, Atalel Fentahun Awedew, Alaa Badawi, Kathleen S. Sachiko Berfield, Kidanemaryam Berhe, Krittika Bhattacharyya, Antonio Biondi, Tone Bjørge, Antonio M. Borzì, Cristina Bosetti, Giulia Carreras, Felix Carvalho, Clara Castro, Dinh-Toi Chu, Vera Marisa Costa, Baye Dagnew, Jiregna Darega Gela, Ahmad Daryani, Feleke Mekonnen Demeke, Gebre Teklemariam Demoz, Mostafa Dianatinasab, Iffat Elbarazi, Mohammad Hassan Emamian, Arash Etemadi, Pawan Sirwan Faris, Eduarda Fernandes, Irina Filip, Florian Fischer, Mohamed M. Gad, Silvano Gallus, Abadi Kahsu Gebre, Tsegaye Tewelde Gebrehiwot, Gebreamlak Gebremedhn Gebremeskel, Begashaw Melaku Gebresillassie, Fatemah Ghasemi-Kebria, Ahmad Ghashghaee, Nermin Ghith, Mahaveer Golechha, Giuseppe Gorini, Rahul Gupta, Nima Hafezi-Nejad, Arvin Haj-Mirzaian, James D. Harvey, Maryam Hashemian, Hamid Yimam Hassen, Simon I. Hay, Andualem Henok, Chi Linh Hoang, H. Dean Hosgood, Mowafa Househ, Olayinka Stephen Ilesanmi, Milena D. Ilic, Seyed Sina Naghibi Irvani, Charvi Jain, Spencer L. James, Sun Ha Jee, Ravi Prakash Jha, Farahnaz Joukar, Ali Kabir, Amir Kasaeian, Mesfin Wudu Kassaw, Supreet Kaur, Andre Pascal Kengne, Esma Kerboua, Yousef Saleh Khader, Rovshan Khalilov, Ejaz Ahmad Khan, Abdullah T. Khoja, Jonathan M. Kocarnik, Hamidreza Komaki, Vivek Kumar, Carlo La Vecchia, Savita Lasrado, Bingyu Li, Alan D. Lopez, Azeem Majeed, Navid Manafi, Ana Laura Manda, Fariborz Mansour-Ghanaei, Manu Raj Mathur, Varshil Mehta, Dhruv Mehta, Walter Mendoza, Prasanna Mithra, Karzan Abdulmuhsin Mohammad, Abdollah Mohammadian-Hafshejani, Reza Mohammadpourhodki, Jemal Abdu Mohammed, Farnam Mohebi, Ali H. Mokdad, Lorenzo Monasta, Delaram Moosavi, Mahmood Moosazadeh, Ghobad Moradi, Farhad Moradpour, Rahmatollah Moradzadeh, Gurudatta Naik, Lonut Negoi, Haruna Asura Nggada, Huong Lan Thi Nguyen, Rajan Nikbakhsh, Molly R. Nixon, Andrew T. Olagunju, Jagadish Roa. Padubidri, Keyvan Pakshir, Shanti Patel, Mona Pathak, Hai Quang Pham, Akram Pourshams, Navid Rabiee, Mohammad Rabiee, Amir Radfar, Alireza Rafiei, Kiana Ramezanzadeh, Goura Kishor Rath, Priya Rathi, Salman Rawaf, David Laith Rawaf, Nima Rezaei, Elias Merdassa Roro, Anas M. Saad, Hamideh Salimzadeh, Abdallah M. Samy, Benn Sartorius, Arash Sarvaezad, Mario Sekerija, Feng Sha, Morteza Shamsizadeh, Sara Sheikhbahaei, Reza Shirkoohi, Sudeep K. Siddappa Malleshappa, Jasvinder A. Singh, Dhirendra Narain Sinha, Catalin-Gabriel Smarandache, Sergey Soshnikov, Hafiz Ansar Rasul Suleria, Degena Bahrey Tadesse, Berhe Etsay Tesfay, Bhaskar Thakur, Eugenio Traini, Khanh Bao Tran, Bach Xuan Tran, Irfan Ullah, Marco Vacante, Yousef Veisani, Isidora S. Vujcic, Girmay Teklay Weldesamuel, Rixing Xu, Vahid Yazdi-Feyzabadi, Deniz Yuce, Vesna Zadnik, Zoubida Zaidi, Zhi-Jiang Zhang, Reza Malekzadeh, Mohsen Naghavi, Gbd 2017 Oesophageal Cancer Collaborators Jan 2020

The Global, Regional, And National Burden Of Oesophageal Cancer And Its Attributable Risk Factors In 195 Countries And Territories, 1990-2017: A Systematic Analysis For The Global Burden Of Disease Study 2017, Farin Kamangar, Dariush Nasrollahzadeh, Saeid Safiri, Sadaf G. Sepanlou, Christina Fitzmaurice, Kevin S. Ikuta, Catherine Bisignano, Farhad Islami, Gholamreza Roshandel, Stephen S. Lim, Hassan Abolhassani, Eman Abu-Gharbieh, Rufus Adesoji Adedoyin, Shailesh M. Advani, Muktar Beshir Ahmed, Miloud Taki Eddine Aichour, Tomi Akinyemiju, Chisom Joyqueenet Akunna, Fares Alahdab, Vahid Alipour, Amir Almasi-Hashiani, Abdulaziz M. Almulhim, Nahla Hamed Anber, Alireza Ansari-Moghaddam, Jalal Arabloo, Morteza Arab-Zozani, Atalel Fentahun Awedew, Alaa Badawi, Kathleen S. Sachiko Berfield, Kidanemaryam Berhe, Krittika Bhattacharyya, Antonio Biondi, Tone Bjørge, Antonio M. Borzì, Cristina Bosetti, Giulia Carreras, Felix Carvalho, Clara Castro, Dinh-Toi Chu, Vera Marisa Costa, Baye Dagnew, Jiregna Darega Gela, Ahmad Daryani, Feleke Mekonnen Demeke, Gebre Teklemariam Demoz, Mostafa Dianatinasab, Iffat Elbarazi, Mohammad Hassan Emamian, Arash Etemadi, Pawan Sirwan Faris, Eduarda Fernandes, Irina Filip, Florian Fischer, Mohamed M. Gad, Silvano Gallus, Abadi Kahsu Gebre, Tsegaye Tewelde Gebrehiwot, Gebreamlak Gebremedhn Gebremeskel, Begashaw Melaku Gebresillassie, Fatemah Ghasemi-Kebria, Ahmad Ghashghaee, Nermin Ghith, Mahaveer Golechha, Giuseppe Gorini, Rahul Gupta, Nima Hafezi-Nejad, Arvin Haj-Mirzaian, James D. Harvey, Maryam Hashemian, Hamid Yimam Hassen, Simon I. Hay, Andualem Henok, Chi Linh Hoang, H. Dean Hosgood, Mowafa Househ, Olayinka Stephen Ilesanmi, Milena D. Ilic, Seyed Sina Naghibi Irvani, Charvi Jain, Spencer L. James, Sun Ha Jee, Ravi Prakash Jha, Farahnaz Joukar, Ali Kabir, Amir Kasaeian, Mesfin Wudu Kassaw, Supreet Kaur, Andre Pascal Kengne, Esma Kerboua, Yousef Saleh Khader, Rovshan Khalilov, Ejaz Ahmad Khan, Abdullah T. Khoja, Jonathan M. Kocarnik, Hamidreza Komaki, Vivek Kumar, Carlo La Vecchia, Savita Lasrado, Bingyu Li, Alan D. Lopez, Azeem Majeed, Navid Manafi, Ana Laura Manda, Fariborz Mansour-Ghanaei, Manu Raj Mathur, Varshil Mehta, Dhruv Mehta, Walter Mendoza, Prasanna Mithra, Karzan Abdulmuhsin Mohammad, Abdollah Mohammadian-Hafshejani, Reza Mohammadpourhodki, Jemal Abdu Mohammed, Farnam Mohebi, Ali H. Mokdad, Lorenzo Monasta, Delaram Moosavi, Mahmood Moosazadeh, Ghobad Moradi, Farhad Moradpour, Rahmatollah Moradzadeh, Gurudatta Naik, Lonut Negoi, Haruna Asura Nggada, Huong Lan Thi Nguyen, Rajan Nikbakhsh, Molly R. Nixon, Andrew T. Olagunju, Jagadish Roa. Padubidri, Keyvan Pakshir, Shanti Patel, Mona Pathak, Hai Quang Pham, Akram Pourshams, Navid Rabiee, Mohammad Rabiee, Amir Radfar, Alireza Rafiei, Kiana Ramezanzadeh, Goura Kishor Rath, Priya Rathi, Salman Rawaf, David Laith Rawaf, Nima Rezaei, Elias Merdassa Roro, Anas M. Saad, Hamideh Salimzadeh, Abdallah M. Samy, Benn Sartorius, Arash Sarvaezad, Mario Sekerija, Feng Sha, Morteza Shamsizadeh, Sara Sheikhbahaei, Reza Shirkoohi, Sudeep K. Siddappa Malleshappa, Jasvinder A. Singh, Dhirendra Narain Sinha, Catalin-Gabriel Smarandache, Sergey Soshnikov, Hafiz Ansar Rasul Suleria, Degena Bahrey Tadesse, Berhe Etsay Tesfay, Bhaskar Thakur, Eugenio Traini, Khanh Bao Tran, Bach Xuan Tran, Irfan Ullah, Marco Vacante, Yousef Veisani, Isidora S. Vujcic, Girmay Teklay Weldesamuel, Rixing Xu, Vahid Yazdi-Feyzabadi, Deniz Yuce, Vesna Zadnik, Zoubida Zaidi, Zhi-Jiang Zhang, Reza Malekzadeh, Mohsen Naghavi, Gbd 2017 Oesophageal Cancer Collaborators

Research outputs 2014 to 2021

© 2020 The Author(s). Background Oesophageal cancer is a common and often fatal cancer that has two main histological subtypes: oesophageal squamous cell carcinoma and oesophageal adenocarcinoma. Updated statistics on the incidence and mortality of oesophageal cancer, and on the disability-adjusted life-years (DALYs) caused by the disease, can assist policy makers in allocating resources for prevention, treatment, and care of oesophageal cancer. We report the latest estimates of these statistics for 195 countries and territories between 1990 and 2017, by age, sex, and Socio-demographic Index (SDI), using data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 …


Evaluation Of A Remote Symptom Assessment And Management (Sam) System For People Receiving Adjuvant Chemotherapy For Breast Or Colorectal Cancer: Mixed Methods Study, Lisa Whitehead, Laura Emery, Deborah Kirk, Diane Twigg, Deborah Brown, Joanna Dewar Jan 2020

Evaluation Of A Remote Symptom Assessment And Management (Sam) System For People Receiving Adjuvant Chemotherapy For Breast Or Colorectal Cancer: Mixed Methods Study, Lisa Whitehead, Laura Emery, Deborah Kirk, Diane Twigg, Deborah Brown, Joanna Dewar

Research outputs 2014 to 2021

©Lisa Whitehead, Laura Emery, Deborah Kirk, Diane Twigg, Deborah Brown, Joanna Dewar. Background: The Symptom Assessment and Management (SAM) program is a structured, online, nurse-supported intervention to support symptom self-management in people receiving adjuvant chemotherapy post surgery for breast or colorectal cancer. Objective: The objective of this study was to describe the development, implementation strategy, and evaluation of the SAM system. Methods: The development of the SAM program involved 3 phases. In phase 1, the web app was developed through consultation with consumers and clinicians and of the literature to ensure that the system was evidence-based and reflected the realities …


Keeping Patients With Cancer Exercising In The Age Of Covid-19, Robert U. Newton, Nicolas H. Hart, Tim Clay Jan 2020

Keeping Patients With Cancer Exercising In The Age Of Covid-19, Robert U. Newton, Nicolas H. Hart, Tim Clay

Research outputs 2014 to 2021

The novel 2019 coronavirus disease (COVID-19) pandemic is a global public health emergency. To date, physical distancing and good personal hygiene have been the only effective measures to limit spread. The pandemic has altered routine cancer care, including allied health and supportive care interventions. Clinicians must adapt and find ways to continue to deliver optimal patient care at this time. The prescription of exercise to people with cancer has been demonstrated to have meaningful benefits for both physical and mental health and quality of life, and may even enhance survival. Such exercise interventions provide the largest benefit to patients when …


Geographical Disparities In Screening And Cancer- Related Health Behaviour, Belinda Goodwin, Arlen K. Rowe, Fiona Crawford-Williams, Peter Baade, Suzanne K. Chambers, Nicholas Ralph, Joanne F. Aitken Jan 2020

Geographical Disparities In Screening And Cancer- Related Health Behaviour, Belinda Goodwin, Arlen K. Rowe, Fiona Crawford-Williams, Peter Baade, Suzanne K. Chambers, Nicholas Ralph, Joanne F. Aitken

Research outputs 2014 to 2021

This study aimed to identify whether cancer-related health behaviours including participation in cancer screening vary by geographic location in Australia. Data were obtained from the 2014–2015 Australian National Health Survey, a computer-assisted telephone interview that measured a range of health-related issues in a sample of randomly selected households. Chi-square tests and adjusted odds ratios from logistic regression models were computed to assess the association between residential location and cancer-related health behaviours including cancer screening participation, alcohol consumption, smoking, exercise, and fruit and vegetable intake, controlling for age, socio-economic status (SES), education, and place of birth. The findings show insufficient exercise, …


“This Is My Little World…”: Navigating The Group Exercise Experience Of Stay-Fit Members, Olivia Jones Jan 2020

“This Is My Little World…”: Navigating The Group Exercise Experience Of Stay-Fit Members, Olivia Jones

Theses and Dissertations (Comprehensive)

Objective

Cancer is the leading cause of death in Canada, with one in two Canadians expected to develop cancer over their lifetime (Canadian Cancer Society, 2019). Exercise is reportedly a safe therapy to help ease the common side effects of cancer and its treatments (Schmitz et al., 2010). Past research has shown the benefits of group exercise while in treatment for cancer, but there is a dearth of research regarding the impact of long-term group exercise programming for cancer survivors. This phenomenological study explored the lived experiences of group exercise participation for individuals who previously had cancer and were enrolled …


Posttraumatic Growth And Death Anxiety In Caregivers Of Cancer Patients: Phoenix Study, Ali̇ Alkan, Eli̇f Berna Köksoy, Ebru Karci, Asli Alkan, Eduardo Bruera, Fi̇li̇z Çay Şenler Jan 2020

Posttraumatic Growth And Death Anxiety In Caregivers Of Cancer Patients: Phoenix Study, Ali̇ Alkan, Eli̇f Berna Köksoy, Ebru Karci, Asli Alkan, Eduardo Bruera, Fi̇li̇z Çay Şenler

Turkish Journal of Medical Sciences

Background/aim: Posttraumatic growth (PTG) is defined as positive psychological changes following a challenging or traumatic life event. The purpose of this study is to define the predictors of PTG and death anxiety (DAN) in caregivers of cancer patients and evaluate the impact of DAN on PTG.Materials and methods: The caregivers of cancer patients were evaluated using structured questionnaires, including a validated PTG scale and Templer death anxiety scale.Results: In 3 different cancer centers, 426 participants were evaluated. In multivariate analysis of factors associated with PTG, a high DAN score was the only parameter associated with high PTG scores [OR: 1.6, …


Summary Of Cancer Among Aboriginal And Torres Strait Islander People, Australian Indigenous Healthinfonet Jan 2020

Summary Of Cancer Among Aboriginal And Torres Strait Islander People, Australian Indigenous Healthinfonet

Research outputs 2014 to 2021

No abstract provided.


Mitochondria Imaging And Targeted Cancer Treatment, Tinghan Zhao Dec 2019

Mitochondria Imaging And Targeted Cancer Treatment, Tinghan Zhao

Dissertations

Mitochondria are essential organelles as the site of respiration in eukaryotic cells and are involved in many crucial functions in cell life. Dysfunction of mitochondrial metabolism and irregular morphology have been frequently found in human cancers. The capability of imaging mitochondria as well as regulating their microenvironment is important both scientifically and clinically. Mitochondria penetrating peptides (MPPs), certain peptides that are composed of cationic and hydrophobic amino acids, are good candidates for mitochondria targeting. Herein, a novel MPP, D-argine-phenylalanine-D-argine-phenylalanine-D-argine-phenylalanine-NH2 (rFrFrF), is conjugated with a rhodamine-based fluorescent chromophore (TAMRA). The TAMRA-rFrFrF probe exhibits advantageous properties for long-term mitochondria tracking of …


Chloroquine Induction Par-4 And Treatment Of Cancer, Vivek M. Rangnekar Dec 2019

Chloroquine Induction Par-4 And Treatment Of Cancer, Vivek M. Rangnekar

Radiation Medicine Faculty Patents

Described herein are methods for treating cancer in a subject in need thereof by administering chloroquine, or a salt or prodrug thereof, optionally with another agent that promotes Par-4 production to induce prostate apoptosis response-4 (Par-4) production by host cells, particularly non-cancerous host cells, to promote apoptosis in cancer cells, including androgen insensitive prostate cancer cells.


Mta3 Represses Cancer Stemness By Targeting The Sox2ot/Sox2 Axis, Liang Du, Lu Wang, Jinfeng Gan, Zhimeng Yao, Wan Lin, Junkuo Li, Yi Guo, Yuping Chen, Fuyou Zhou, Sai-Ching Jim Yeung, Robert P Coppes, Dianzheng Zhang, Hao Zhang Dec 2019

Mta3 Represses Cancer Stemness By Targeting The Sox2ot/Sox2 Axis, Liang Du, Lu Wang, Jinfeng Gan, Zhimeng Yao, Wan Lin, Junkuo Li, Yi Guo, Yuping Chen, Fuyou Zhou, Sai-Ching Jim Yeung, Robert P Coppes, Dianzheng Zhang, Hao Zhang

PCOM Scholarly Works

Cancer cell stemness (CCS) plays critical roles in both malignancy maintenance and metastasis, yet the underlying molecular mechanisms are far from complete. Although the importance of SOX2 in cancer development and CCS are well recognized, the role of MTA3 in these processes is unknown. In this study, we used esophageal squamous cell carcinoma (ESCC) as a model system to demonstrate that MTA3 can repress both CCS and metastasis in vitro and in vivo. Mechanistically, by forming a repressive complex with GATA3, MTA3 downregulates SOX2OT, subsequently suppresses the SOX2OT/SOX2 axis, and ultimately represses CCS and metastasis. More importantly, MTA3


Burden And Risk Of Non-Aids Defining Cancers In Hiv-Infected Persons Receiving Antiretroviral Therapy, Brittney L. Dickey Dec 2019

Burden And Risk Of Non-Aids Defining Cancers In Hiv-Infected Persons Receiving Antiretroviral Therapy, Brittney L. Dickey

Theses & Dissertations

The burden of cancers not previously associated with an HIV infection, called non-AIDS defining cancers (NADCs), have increased in the years since highly active anti-retroviral therapy has been introduced. The studies in this dissertation attempted to quantify this burden via incidence and mortality compared to the general population. Further, an assessment of risk factors and creation of a predictive risk model, a nomogram, were utilized to better understand how factors associated with demographics, lifestyle, and immune response affected risk for an NADC diagnosis once therapy was initiated and HIV better controlled. Standardized incidence and mortality ratios showed that burden of …


Amphiphilic Cell-Penetrating Hybrid Cyclic-Linear Peptides As A Drug Delivery System, Saghar Mozaffari Dec 2019

Amphiphilic Cell-Penetrating Hybrid Cyclic-Linear Peptides As A Drug Delivery System, Saghar Mozaffari

Pharmaceutical Sciences (PhD) Dissertations

A number of cyclic peptides containing a positively charged ring composed of arginine residues attached to hydrophobic tail made of tryptophan residues through a lysine linker namely [R5K]W5, [R6K]W5, [R5K]W6, [R7K]W5, [R5K]W7, [R6K]W6, and [R7K]W7 were synthesized and evaluated as molecular transporters. The peptides were evaluated for their ability to deliver, fluorescence-labeled cell-impermeable negatively charged phosphopeptide (F′-GpYEEI), and fluorescent labeled anti-HIV drugs (F′-FTC and F′-d4T). The results indicated that the presence of positively …


Putting A Face To Cancer, Lenn Robbins Dec 2019

Putting A Face To Cancer, Lenn Robbins

Capstones

About one month after I began my studies at the Craig Newmark Graduate School of Journalism, I was diagnosed with a rare form of cancer, Langerhans Cell Histiocytosis (LCH). Three years and three relapses later, I have my MA, I defiant will to fight this disease and the hope that by chronicling my experience I might help others. If this project helps just one person, it's been worth the ride.

https://lennrobbins.wixsite.com/facetocancer


Synthesis Of Gadolinium-Doxorubicin Prodrug Carrying Functional Nanoceria For The Targeted Drug Delivery And Cancer Treatment, Arth Patel Dec 2019

Synthesis Of Gadolinium-Doxorubicin Prodrug Carrying Functional Nanoceria For The Targeted Drug Delivery And Cancer Treatment, Arth Patel

Electronic Theses & Dissertations

The main focus of this research was the development of a polymer-coated nanoceria (PNC) platform to be used as a drug delivery system. Water-dispersible PNC is synthesized using a water-based alkaline precipitation method. Cerium nitrate hexahydrate and poly (acrylic acid) are used for the preparation of PNC. The synthesized PNC was characterized using ZETA, and UV- Vis characterization techniques. Polyacrylic acid (PAA)-coated cerium oxide nanoparticles fabricated for the targeted combination therapy of TNBC (MDA-MB-231) and MCF-7. Using EDC/NHS chemistry, the surface carboxylic acid groups of nanoceria was designed and synthesized with ICAM-1 antibody to target ICAM-1 overexpressing TNBC. Next, doxorubicin …


Disaggregated Hispanic Groups And Cancer: Importance, Methodology, And Current Knowledge, Paulo S. Pinheiro, Karen E. Callahan, Erin N. Kobetz Dec 2019

Disaggregated Hispanic Groups And Cancer: Importance, Methodology, And Current Knowledge, Paulo S. Pinheiro, Karen E. Callahan, Erin N. Kobetz

Environmental & Global Health Faculty Research

Cancer is the leading cause of death among Latinos/Hispanics, the largest racial/ethnic minority group in the United States. Their cancer burden has nearly doubled in 15 years, with 129,000 new cancer cases nationwide in 2014. As this relatively young Hispanic population ages, this burden will inevitably increase; thus, accurate characterization of the Hispanic cancer experience is critical. In this chapter, we summarize the current knowledge on cancer in Hispanics, with a focus on the imperative of disaggregating by specific Hispanic group (Mexicans, Puerto Ricans, Cubans, Central Americans, South Americans, and Dominicans) and nativity. We also describe for the first time …


Interaction Of The Oncoprotein Transcription Factor Myc With Its Chromatin Cofactor Wdr5 Is Essential For Tumor Maintenance., Lance R. Thomas, Clare M. Adams, Jing Wang, April M. Weissmiller, Joy Creighton, Shelly L. Lorey, Qi Liu, Stephen W. Fesik, Christine M. Eischen, William P. Tansey Dec 2019

Interaction Of The Oncoprotein Transcription Factor Myc With Its Chromatin Cofactor Wdr5 Is Essential For Tumor Maintenance., Lance R. Thomas, Clare M. Adams, Jing Wang, April M. Weissmiller, Joy Creighton, Shelly L. Lorey, Qi Liu, Stephen W. Fesik, Christine M. Eischen, William P. Tansey

Department of Cancer Biology Faculty Papers

The oncoprotein transcription factor MYC is overexpressed in the majority of cancers. Key to its oncogenic activity is the ability of MYC to regulate gene expression patterns that drive and maintain the malignant state. MYC is also considered a validated anticancer target, but efforts to pharmacologically inhibit MYC have failed. The dependence of MYC on cofactors creates opportunities for therapeutic intervention, but for any cofactor this requires structural understanding of how the cofactor interacts with MYC, knowledge of the role it plays in MYC function, and demonstration that disrupting the cofactor interaction will cause existing cancers to regress. One cofactor …


7-Epi-Clusianone, A Multi-Targeting Natural Product With Potential Chemotherapeutic, Immune-Modulating, And Anti-Angiogenic Properties, Wesley F. Taylor, Maria Yanez, Sara E. Moghadam, Mahdi Moridi Farimani, Sara Soroury, Samad N. Ebrahimi, Marzieh Tabefam, Ehsan Jabbarzadeh Dec 2019

7-Epi-Clusianone, A Multi-Targeting Natural Product With Potential Chemotherapeutic, Immune-Modulating, And Anti-Angiogenic Properties, Wesley F. Taylor, Maria Yanez, Sara E. Moghadam, Mahdi Moridi Farimani, Sara Soroury, Samad N. Ebrahimi, Marzieh Tabefam, Ehsan Jabbarzadeh

Faculty Publications

Targeted therapies have changed the treatment of cancer, giving new hope to many patients in recent years. The shortcomings of targeted therapies including acquired resistance, limited susceptible patients, high cost, and high toxicities, have led to the necessity of combining these therapies with other targeted or chemotherapeutic treatments. Natural products are uniquely capable of synergizing with targeted and non-targeted anticancer regimens due to their ability to affect multiple cellular pathways simultaneously. Compounds which provide an additive effect to the often combined immune therapies and cytotoxic chemotherapies, are exceedingly rare. These compounds would however provide a strengthening bridge between the two …


Case Presentation On Urinary Bladder Cancer And Cysto-Prostatectomy, Tetiana Soloviova Nov 2019

Case Presentation On Urinary Bladder Cancer And Cysto-Prostatectomy, Tetiana Soloviova

Publications and Research

Patients who have invasive bladder cancer (spread to different tissues and organs) may need to have a radical cystectomy type of surgery. In male patients, the surgeon usually removes the prostate and seminal vesicles in addition to the bladder, parts of the ureters, and lymph nodes (Nicholson, 2017, ¶ 1)

In our case a reconstructive surgery followed right after removing of the bladder and prostate gland. A different way of urine to be stored and passed from the patient’s body was created by the surgeon. A part of small intestine was used to make up a reservoir that will serve …


“Making Do, As Best As We Can” Cancer In American Samoa: Qualitative Methods And Results, Va'atausili Tofaeono, Tyran Terada, Luana Sue Kaopua, Angela Sy, Luana Yoshikawa Nov 2019

“Making Do, As Best As We Can” Cancer In American Samoa: Qualitative Methods And Results, Va'atausili Tofaeono, Tyran Terada, Luana Sue Kaopua, Angela Sy, Luana Yoshikawa

Journal of Health Disparities Research and Practice

Purpose/Background: The United Nation outlines a blueprint for addressing social determinants of health (SDOH), reconciling disparities between and within countries. Indigenous people living in Small Island Developing States like the U.S. territories experience health disparities. In American Samoa (AS), SDOH involving political, social, and data limitations provide challenges to in-country research and health services delivery capacity including cancer prevention and treatment. For example, in AS less than 7% of age-eligible adults participated in colorectal cancer (CRC) screening, while the Healthy People 2020 target is 70% screened. In 2004 a cancer awareness and service needs assessment in AS funded by the …